Russo, F. P.; Burra, P.; Rugge, M.; Wright, N. A.; Alison, M. R.; Forbes, S. J.
April 2004
Gut;Apr2004 Supplement 3, Vol. 53, pA12
Academic Journal
Myofibroblasts of bone marrow origin have recently been found in a number of parenchymal organs such as the gut and kidney. Authors sought to analyse the origin of myofibroblasts within fibrotic liver in two scenarios: 8 male patients, who received liver transplants from female donors and subsequently developed liver fibrosis and a female recipient of a male bone marrow transplant who later developed hepatitis C induced cirrhosis. There is a significant contribution to liver cirrhosis in humans from extrahepatically derived myofibroblasts in liver disease of diverse aetiology.


Related Articles

  • HCV and Diabetes Mellitus: Evidence for a Negative Association. Mangia, Alessandra; Schiavone, Giuseppe; Lezzi, Giovanni; Marmo, Riccardo; Bruno, Francesco; Villani, Maria Rosaria; Cascavilla, Isabella; Fantasia, Luigi; Andriulli, Angelo // American Journal of Gastroenterology;Dec1998, Vol. 93 Issue 12, p2363 

    Objective: Uncontrolled, retrospective clinical studies have recently claimed that HCV infection could trigger the onset of diabetes mellitus (DM). We sought to verify the association between DM and liver diseases of different etiology, stage, and severity in a prospective study including...

  • Estimated prevalence of Hepatitis C Virus infection in Canada, 2011. Trubnikov, M.; Yan, P.; Archibald, C. // Canada Communicable Disease Report;12/1/2014, Vol. 40 Issue 19, p429 

    Background: Prevalence estimates contribute to our understanding of the magnitude of a particular health condition and in planning appropriate public health interventions. Objective: To estimate the prevalence of chronic Hepatitis C virus (HCV) infection, anti-HCV-positive status (anti-HCV) and...

  • Cognitive Dysfunction in Chronic Hepatitis C: A Review. William Perry; Robin Hilsabeck; Tarek Hassanein // Digestive Diseases & Sciences;Feb2008, Vol. 53 Issue 2, p307 

    Abstract  The hepatitis C virus (HCV) is a common blood-borne illness that affects up to 2% of the world’s population and almost 4 million Americans. Cognitive impairment, or difficulty with thinking, has become a well-established symptom in persons with end stage liver disease....

  • Hepatic encephalomyelopathy: a complication following liver cirrhosis caused by Budd-Chiari syndrome and HBV. Jun Cheng; Shou-Wei Jiang; Zhong-Song Zhou; Qiu-Lin Sun // Journal of Infection in Developing Countries;Apr2014, Vol. 8 Issue 4, p551 

    Progressive encephalomyelopathy is a rare neurological complication of chronic liver disease, even manifesting progressive spastic paraparesis. Few reports detailing the clinical and diagnostic aspects of this uncommon cause of neurological deterioration in patients with hepatic insufficiency...

  • Significance of Elevated IgG Anticardiolipin Antibody Levels in Patients With Budd-Chiari Syndrome. Aggarwal, Rakesh; Ravishankar, B.; Misra, Ramnath; Aggarwal, Amita; Dwivedi, Sanjay; Naik, Subhash R. // American Journal of Gastroenterology;Jun1998, Vol. 93 Issue 6, p954 

    Objectives: Budd-Chiari syndrome (BCS) is characterized by hepatic venous outflow obstruction. Though hypercoagulable states are implicated in the causation of BCS, the etiology remains unknown in most cases. Presence of anticardiolipin antibodies (aCL) is a known cause of hypercoagulable state....

  • Portal hypertensive colopathy is associated with portal hypertension severity in cirrhotic patients. Diaz-Sanchez, Antonio; Nuñez-Martinez, Oscar; Gonzalez-Asanza, Cecilia; Matilla, Ana; Merino, Beatriz; Rincon, Diego; Beceiro, Inmaculada; Catalina, Maria Vega; Salcedo, Magdalena; Bañares, Rafael; Clemente, Gerardo; Mandell, Mercedes Susan // World Journal of Gastroenterology;10/14/2009, Vol. 15 Issue 38, p4781 

    AIM: To assess the prevalence of portal hypertension (PH) related colorectal lesions in liver transplant candidates, and to evaluate its association with the severity of PH. METHODS: Between October 2004 and December 2005, colonoscopy was performed in 92 cirrhotic liver transplant candidates. We...

  • Clinical features and management of primary sclerosing cholangitis. Silveira, Marina G.; Lindor, Keith D.; Kupcinskas, Limas; Jirsa, Milan; Green, Richard M. // World Journal of Gastroenterology;6/7/2008, Vol. 14 Issue 21, p3338 

    Primary sclerosing cholangitis is a chronic cholestatic liver disease characterized by inflammation and fibrosis of the bile ducts, resulting in cirrhosis and need for liver transplantation and reduced life expectancy. The majority of cases occur in young and middle-aged men, often in...

  • Rapid Progression of Primary Sclerosing Cholangitis Complicated with Ulcerative Colitis. Pardak, Piotr; Walczak, Ewa; Filip, Rafał S. // Case Reports in Gastrointestinal Medicine;1/28/2015, Vol. 2015, p1 

    Primary sclerosing cholangitis is a cholestatic condition with unknown etiology and long-standing, progressive course, leading to cirrhosis and requiring orthotropic liver transplant. In approximately 80%, primary sclerosing cholangitis is accompanied by inflammatory bowel disease, and in most...

  • Generic and disease-specific health related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: a cross-sectional study. Van Der Plas, Simone M.; Hansen, Bettina E.; De Boer, Josien B.; Stijnen, Theo; Passchier, Jan; De Man, Robert A.; Schalm, Solko W. // BMC Gastroenterology;2003, Vol. 3, p33 

    Background: Studies on Health Related Quality of Life (HRQoL) of chronic liver patients were performed in clinical populations. These studies included various disease stages but small variations in aetiology and no transplanted patients. We performed a large HRQoL study in non-cirrhotic,...


Read the Article


Sign out of this library

Other Topics